Empagliflozin attenuates traumatic brain injury-induced atherosclerosis and norepinephrine-induced vascular smooth muscle cell responses
Scientific Reports, Published online: 08 October 2026; doi:10.1038/s41598-026-73123-4 Empagliflozin attenuates traumatic brain injury-induced atherosclerosis and norepinephrine-induced vascular smooth muscle cell responses
We haven't written up this one. Scientific Reports has the full story — the link below goes straight to it.